4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-23-007180
EVP R&D, Chief Medical Officer gave up 5,345 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 12,038 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-22 | Exercise or conversion : show line 1 in the form | +12,038 | 61,904 | D | ||
| 2023-02-22 | Shares withheld for taxes : show line 2 in the form | −5,345 | $27.77 | $148,431 | 56,559 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-22 | Exercise or conversion : show line 3 in the form Restricted Stock Unit Award | −12,038 | 24,076 | D |
| 2023-02-23 | Grant or award : show line 4 in the form Employee Stock Option (Right to Buy) | +120,615 | 120,615 | D |
| 2023-02-23 | Grant or award : show line 5 in the form Restricted Stock Unit Award | +30,154 | 30,154 | D |
Loading xslF345X03/form4.xml…